A clinical trial of a liver cancer treatment at the Goshen Health System Center for Cancer Care, the only one of its kind in the United States, is yielding promising results, says Dr. Seza Gulec, who oversees the study. Gulec, who heads the endocrine surgery, hepatic oncology, molecular imaging and position emission tomography programs at the Goshen Center for Cancer Care, led the fourth annual clinical symposium on liven directed therapy in Chicago recently. The Goshen center hosted the event. During the symposium, he presented his groundbreaking study on the treatment of liver cancer that has reached the threshold of 20 patients and is returning positive results. The process is called Y- 90 microsphere Selective...















Recent comments
12 weeks 3 days ago